Newsletter
DSCSA Provisions Delayed While Counterfeits Continue
There is still much to be done to get to the DSCSA’s vision of an electronic, interoperable system to trace pharmaceutical products | Catalyst Corner | By Marsha Millonig
Newsletter
There is still much to be done to get to the DSCSA’s vision of an electronic, interoperable system to trace pharmaceutical products | Catalyst Corner | By Marsha Millonig
One opportunity for an additional revenue stream is for pharmacists to provide and bill for a multitude of clinical services | Viewpoints | By Patricia Milazzo and Logan Graham
Newsletter
Understanding what your pharmacy's patients are using to track their health and wellness can offer an opportunity to help them achieve their health goals in 2024 | Technology Corner | By Brent Fox
Newsletter
DIR fees, reimbursements, time constraints, regulatory requirements, and profitability are top of mind today, and this list seems to grow with every pharmacist you speak with. | Sponsored
Newsletter
Q&A with Medicine-On-Time’s Tori Pearson on how adherence tools make a positive impact on inventory.
It seems as if there’s always a cloud hanging over pharmacy finances. And now there’s a full-fledged storm of direct and indirect remuneration (DIR) fees brewing during these first few months of 2024.
The honorees were singled out by thousands of voters in the industry as being among those that are forging a new and better future for pharmacy.
Newsletter
Over the past 20 years Theresa Tolle, owner of Bay Street Pharmacy in Sebastian, Fla., has seen changes and developed the business to keep pace.
Newsletter
Case Study | Streamline Your Pharmacy Inventory and Navigate DIR Fees with Ease. | Sponsored
Newsletter
PDF Print Edition
Newsletter
VIDEO|TEXT Pharmacy News Update Jan. 31, 2024
Newsletter
“Product thought leadership” is the theme of a comprehensive solution to a seamless workflow from PrimeRx.